Baxter International Inc.
"Sector" = median of Healthcare across 84 companies
About Baxter International Inc.
AI-generatedBaxter International Inc. is a global healthcare company specializing in medical devices, pharmaceuticals, and biotechnology. It focuses on critical care, nutrition, renal care, and hospital products. The company develops and manufactures products such as intravenous (IV) solutions, infusion pumps, dialysis equipment, and surgical sealants. Baxter operates in over 100 countries, serving hospitals, clinics, and home care settings.
Baxter generates revenue primarily through two segments: Medical Products and Therapeutics, and Healthcare Systems and Technologies. The Medical Products segment includes IV therapies, parenteral nutrition, and renal care products. The Healthcare Systems segment provides infusion systems, pharmacy automation, and surgical products. Revenue is diversified across product lines and geographies, with the US being the largest market. The company's business model relies on recurring sales of consumables and services, as well as capital equipment.
Baxter operates in the Medical Instruments & Supplies industry within the Healthcare sector. It competes with companies like Becton Dickinson, Fresenius Medical Care, and B. Braun. Baxter holds a strong position in renal care and IV solutions, but faces challenges from pricing pressures and competition. The company has a large installed base of infusion pumps and a broad portfolio, which provides some competitive advantage. However, its financial metrics show low profitability and high debt levels.
Baxter's primary customers are hospitals, clinics, dialysis centers, and home care providers. Its products are used by healthcare professionals in critical care, surgery, and chronic disease management. Geographically, the US accounts for about 60% of revenue, with Europe, Asia Pacific, and emerging markets contributing the rest. The company targets both developed and developing markets, focusing on expanding access to renal care and hospital products.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: March 2026 · 2026-03-31
Dividend history
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Feb 27, 2026 | $0.01 | Apr 1, 2026 | Quarterly |
| Nov 28, 2025 | $0.01 | Jan 2, 2026 | Quarterly |
| Aug 29, 2025 | $0.17 | Oct 1, 2025 | Quarterly |
| May 30, 2025 | $0.17 | Jul 1, 2025 | Quarterly |
| Feb 28, 2025 | $0.17 | Apr 1, 2025 | Quarterly |
| Nov 29, 2024 | $0.17 | Jan 2, 2025 | Quarterly |
| Aug 30, 2024 | $0.29 | Oct 1, 2024 | Quarterly |
| May 31, 2024 | $0.29 | Jul 1, 2024 | Quarterly |
| Feb 29, 2024 | $0.29 | Apr 1, 2024 | Quarterly |
| Nov 30, 2023 | $0.29 | Jan 2, 2024 | Quarterly |
| Aug 31, 2023 | $0.29 | Oct 2, 2023 | Quarterly |
| Jun 1, 2023 | $0.29 | Jul 3, 2023 | Quarterly |
| Feb 23, 2023 | $0.29 | Apr 3, 2023 | Quarterly |
| Dec 1, 2022 | $0.29 | Jan 3, 2023 | Quarterly |
| Sep 1, 2022 | $0.29 | Oct 3, 2022 | Quarterly |
| Jun 2, 2022 | $0.29 | Jul 1, 2022 | Quarterly |
| Feb 24, 2022 | $0.28 | Apr 1, 2022 | Quarterly |
| Dec 2, 2021 | $0.28 | Jan 3, 2022 | Quarterly |
| Sep 2, 2021 | $0.28 | Oct 1, 2021 | Quarterly |
| Jun 3, 2021 | $0.28 | Jul 1, 2021 | Quarterly |
| Feb 25, 2021 | $0.25 | Apr 1, 2021 | Quarterly |
| Dec 3, 2020 | $0.25 | Jan 4, 2021 | Quarterly |
| Aug 28, 2020 | $0.25 | Oct 1, 2020 | Quarterly |
| Jun 4, 2020 | $0.25 | Jul 1, 2020 | Quarterly |
Revenue
↓ 0.6%Net Income
↓ 106.1%Free Cash Flow
↓ 67.0%Diluted EPS
↑ 97.0%Baxter International Inc. (BAX) analysis
Wrqti brings Baxter International Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Stocks related to Baxter International Inc.
Companies in the Healthcare sector you can compare with Baxter International Inc.: